CytoMed Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GDTC and other ETFs, options, and stocks.About GDTC
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments.
CEOWee Kiat Tan, PhD
CEOWee Kiat Tan, PhD
Employees43
Employees43
HeadquartersSingapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded2018
Founded2018
Employees43
Employees43
GDTC Key Statistics
Market cap22.41M
Market cap22.41M
Price-Earnings ratio-7.95
Price-Earnings ratio-7.95
Dividend yield—
Dividend yield—
Average volume107.25K
Average volume107.25K
High today$1.91
High today$1.91
Low today$1.86
Low today$1.86
Open price$1.86
Open price$1.86
Volume8.78K
Volume8.78K
52 Week high$4.05
52 Week high$4.05
52 Week low$1.65
52 Week low$1.65
Stock Snapshot
With a market cap of 22.41M, CytoMed Therapeutics(GDTC) trades at $1.91. The stock has a price-to-earnings ratio of -7.95.
On 2025-11-25, CytoMed Therapeutics(GDTC) stock traded between a low of $1.86 and a high of $1.91. Shares are currently priced at $1.91, which is +3.0% above the low and 0.0% below the high.
CytoMed Therapeutics(GDTC) shares are trading with a volume of 8.78K, against a daily average of 107.25K.
In the last year, CytoMed Therapeutics(GDTC) shares hit a 52-week high of $4.05 and a 52-week low of $1.65.
In the last year, CytoMed Therapeutics(GDTC) shares hit a 52-week high of $4.05 and a 52-week low of $1.65.
People also own
Based on the portfolios of people who own GDTC. This list is generated using Robinhood data, and it’s not a recommendation.